PubMedopen access
Beyond Public Health and Medicine: The Potential Impact of GLP-1s and Other Incretin Mimetic Medications on Greenhouse Gas Emissions.
glucagon-like peptide 1, humans, greenhouse gases, incretins, public health, carbon footprint
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 389555
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.